TIGIT overexpression diminishes the function of CD4 T cells and ameliorates the severity of rheumatoid arthritis in mouse models

Experimental Cell Research

Volumn 340, Issue 1, 2016, Pages 132-138

  Zhao, Weigong ^a   Dong, Yanying ^a   Wu, Caijun ^a   Ma, Yunfeng ^a   Jin, Yaofeng ^a   Ji, Yanhong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

CD4 T cell; Rheumatoid arthritis; Synovial fluid; TIGIT

Indexed keywords

COLLAGEN TYPE 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; SMALL INTERFERING RNA; IMMUNOGLOBULIN RECEPTOR; TIGIT PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; LENTIVIRUS INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T CELL IMMUNOGLOBULIN AND IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DISEASE MODEL; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; RECEPTORS, IMMUNOLOGIC; SYNOVIAL FLUID; UP-REGULATION;

EID: 84953635468     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.12.002     Document Type: Article

References (26)

1. Feldmann M., Brennan F.M., Maini R.N. Rheumatoid arthritis. Cell 1996, 85:307-310.
2. Skapenko A., Lipsky P.E., Schulze-Koops H. T cell activation as starter and motor of rheumatic inflammation. Curr. Top. Microbiol. Immunol. 2006, 305:195-211.
3. Cope A.P., Schulze-Koops H., Aringer M. The central role of T cells in rheumatoid arthritis. Clin. Exp. Rheumatol. 2007, 25:S4-11.
4. Dolhain R.J., van der Heiden A.N., ter Haar N.T., Breedveld F.C., Miltenburg A.M. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 1996, 39:1961-1969.
5. Hwang S.Y., Kim H.Y. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol. Cells 2005, 19:180-184.
6. Fiocco U., Sfriso P., Oliviero F., Pagnin E., Scagliori E., Campana C., Dainese S., Cozzi L., Punzi L. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun. Rev. 2008, 8:76-82.
7. Cutolo M., Nadler S.G. Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis. Autoimmun. Rev. 2013, 12:758-767.
8. Cutolo M., Soldano S., Montagna P., Sulli A., Seriolo B., Villaggio B., Triolo P., Clerico P., Felli L., Brizzolara R. CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. Arthritis Res. Ther. 2009, 11:R176.
9. Weisman M.H., Durez P., Hallegua D., Aranda R., Becker J.C., Nuamah I., Vratsanos G., Zhou Y., Moreland L.W. Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis. J. Rheumatol. 2006, 33:2162-2166.
10. Lozano E., Dominguez-Villar M., Kuchroo V., Hafler D.A. The TIGIT/CD226 axis regulates human T cell function. J. Immunol. 2012, 188:3869-3875.
11. Yu X., Harden K., Gonzalez L.C., Francesco M., Chiang E., Irving B., Tom I., Ivelja S., Refino C.J., Clark H., Eaton D., Grogan J.L. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 2009, 10:48-57.
12. Stanietsky N., Simic H., Arapovic J., Toporik A., Levy O., Novik A., Levine Z., Beiman M., Dassa L., Achdout H., Stern-Ginossar N., Tsukerman P., Jonjic S., Mandelboim O. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17858-17863.
13. Li M., Xia P., Du Y., Liu S., Huang G., Chen J., Zhang H., Hou N., Cheng X., Zhou L., Li P., Yang X., Fan Z. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-gamma production of natural killer cells via beta-arrestin 2-mediated negative signaling. J. Biol. Chem. 2014, 289:17647-17657.
14. Chan C.J., Martinet L., Gilfillan S., Souza-Fonseca-Guimaraes F., Chow M.T., Town L., Ritchie D.S., Colonna M., Andrews D.M., Smyth M.J. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat. Immunol. 2014, 15:431-438.
15. Zhang T., Wang J., Zhou X., Liang R., Bai Q., Yang L., Gu H., Gao G., Dong B., Zhu H., Chen X. Increased expression of TIGIT on CD4+ T cells ameliorates immune-mediated bone marrow failure of aplastic anemia. J. Cell. Biochem. 2014, 115:1918-1927.
16. Johnston R.J., Comps-Agrar L., Hackney J., Yu X., Huseni M., Yang Y., Park S., Javinal V., Chiu H., Irving B., Eaton D.L., Grogan J.L. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell. 2014, 26:923-937.
17. Chauvin J.M., Pagliano O., Fourcade J., Sun Z., Wang H., Sander C., Kirkwood J.M., Chen T.H., Maurer M., Korman A.J., Zarour H.M. TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients. J. Clin. Investig. 2015, 125:2046-2058.
18. Joller N., Lozano E., Burkett P.R., Patel B., Xiao S., Zhu C., Xia J., Tan T.G., Sefik E., Yajnik V., Sharpe A.H., Quintana F.J., Mathis D., Benoist C., Hafler D.A., Kuchroo V.K. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 2014, 40:569-581.
19. Wells G., Becker J.C., Teng J., Dougados M., Schiff M., Smolen J., Aletaha D., van Riel P.L. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann. Rheum. Dis. 2009, 68:954-960.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
21. Hegen M., Sun L., Uozumi N., Kume K., Goad M.E., Nickerson-Nutter C.L., Shimizu T., Clark J.D. Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritis. J. Exp. Med. 2003, 197:1297-1302.
22. Greenwald R.J., Freeman G.J., Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 2005, 23:515-548.
23. Sharpe A.H., Abbas A.K. T-cell costimulation--biology, therapeutic potential, and challenges. N. Engl. J. Med. 2006, 355:973-975.
24. Kormendy D., Hoff H., Hoff P., Broker B.M., Burmester G.R., Brunner-Weinzierl M.C. Impact of the CTLA-4/CD28 axis on the processes of joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2013, 65:81-87.
25. Pauken K.E., Wherry E.J. TIGIT and CD226: tipping the balance between costimulatory and coinhibitory molecules to augment the cancer immunotherapy toolkit. Cancer Cell. 2014, 26:785-787.
26. Li S., Liao W., Chen M., Shan S., Song Y., Zhang S., Song H., Yuan Z. Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis. Inflammation 2014, 37:116-121.